drug development
Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia
October 27, 2026Chronic Diseases, EMA, Pain, Pharmacy, drug development, regulatory
Sobi’s olezarsen (TRYNGOLZA) has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use …
Amphista doses first patient in AML trial of protein degrader
October 20, 2026AML, FDA, Oncology, clinical trial, drug development, pharma
Amphista Therapeutics has dosed the first patient in a phase 1 trial of AMX-883, an experimental oral therapy targeting acute …
Boyds expands Regulatory Affairs team to support growing demand
October 16, 2026Consultancy, Diagnostics, Pharmacy, drug development, life sciences, regulatory affairs
Vicki Hayes has joined Boyds as Vice President of Regulatory Affairs with Jan Ohotski becoming Director of Regulatory Affairs. Hayes …
Custom Pharmaceuticals launches new company for drug product development
November 12, 2025Business Services Centrix Pharma Solutions, Company Launch, Custom Pharmaceuticals, collaboration, drug development, university of sussex
Customs Pharmaceuticals, a full-service contract development and manufacturing organisation (CDMO), has launched Centrix Pharma Solutions, a new company targeting faster …
VALANX Biotech appoints Klaus Orlinger as Chief Scientific Officer
November 4, 2025Antibody-Drug Conjugate, VALANX Biotech, drug development
VALANX Biotech, a company developing novel technology for site-specific protein conjugation in drug discovery, has appointed Klause Orlinger as Chief …
BioMed X and Novo Nordisk partner on oral peptide drug delivery innovation
August 19, 2025Mergers and Acquisitions, Research and Development BioMed X, Novo Nordisk, Pharmacy, drug development, therapeutic peptides
BioMed X has announced a new collaboration with Novo Nordisk to improve oral delivery of therapeutic peptides – a major …
BioDuro and Silicogenix collaborate to advance non-traditional drug development
June 11, 2025Manufacturing Services, Manufacturing and Production, Research and Development BioDuro, Oncology, Pharmacy, Silicogenix, contract research, contract research development and manufacturing organisation (CRDMO), drug development
BioDuro, a contract research, development and manufacturing organisation, has announced a strategic partnership with small molecule design specialist Silicogenix (SGX) …
Drug discovery and development partnership announced between Apollo Therapeutics and Oxford University
July 31, 2024Clinical Research, Medical Communications, Research and Development Apollo Therapeutics, Internal Medicine, Microbiology, drug development, drug discovery, research
Portfolio therapeutics company Apollo Therapeutics has announced earlier this week that it will provide capital and expertise to Oxford University’s …
Lonza to acquire Synaffix to strengthen ADC development
June 1, 2023Medical Communications ADC, Lonza, Oncology, Synaffix, drug development
Global manufacturer for the pharmaceutical, biotech and nutraceutical markets, Lonza has announced that it has acquired Synaffix, a biotech company …
Merck invests €35m in biosafety testing in Scotland
May 31, 2023Manufacturing and Production Merck, biosafety, drug development, testing
Merck has announced that it has invested €35m in biosafety testing at its sites in Glasgow and Stirling, both Scotland. …
New study calculates median drug development costs at circa $1 billion
March 5, 2020Manufacturing and Production, Research and Development, Sales and Marketing drug development, drug prices, pharma
New research has pinned a concrete figure on the perennial industry question: how much does it cost to bring a …
Number of UK animal testing procedures falls to lowest level since 2007
July 19, 2019Medical Communications, Research and Development Animal testing, UK, drug development, pharma, rresearch
A report from the Home Office of the UK Government has revealed that the prevalence of animal testing in the …
Roche signs deal with Skyhawk over molecules that modulate RNA splicing
July 17, 2019Research and Development Genentech, Roche, Skyhawk, drug development, rna splicing
Roche’s Genentech unit has signed a deal with Massachusetts-based firm Skyhawk Therapeutics to develop and commercialise small molecules that modulate …
Interactions with the Agencies During Drug Development
April 25, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cambridge, NDA, drug development
NDA would like to invite you to join Professor Steffen Thirstrup, Director NDA Advisory Board, formerly Division Head at the Danish Medicines …
Researchers use CRISPR to reveal gene targets in 30 types of cancer
April 11, 2019Research and Development Cancer, crispr, drug development, genes, genetics, oncology
Researchers at the Wellcome Sanger Institute and Open Targets have been able to identify thousands of genes which play a …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
AI: an early warning system for patient safety
